Which Weight Loss Injection Suits Your Health Profile?
Does Wegovy Have Fewer Side Effects Than Mounjaro for Weight Management?
When evaluating whether Wegovy has less side effects than Mounjaro, both prescription-only medicines share similar gastrointestinal effects including nausea, vomiting, and diarrhoea. Clinical trials show that approximately 44% of Wegovy patients experienced nausea compared to around 12% with placebo, whilst Mounjaro trials reported nausea rates between 12-22% depending on the dose. The key difference lies in their mechanisms: Wegovy targets GLP-1 receptors exclusively, whilst Mounjaro activates both GIP and GLP-1 pathways. This dual action may contribute to different side effect experiences between individuals, though direct head-to-head comparison studies are limited.
Both treatments require gradual dose escalation to minimise side effects, starting with lower doses and increasing over 16-20 weeks. Wegovy begins at 0.25mg weekly, progressing to the maintenance dose of 2.4mg, whilst Mounjaro starts at 2.5mg, escalating to either 5mg, 10mg, or 15mg maintenance doses. The question of whether Wegovy has less side effects than Mounjaro ultimately depends on individual tolerance, existing health conditions, and how your body responds to each medication's unique mechanism of action. Your prescriber can assess your medical history to determine which treatment profile aligns better with your health status.
Wegovy vs Mounjaro Pricing and Treatment Value at EverydayMeds
Understanding the cost implications when asking does Wegovy have less side effects than Mounjaro involves examining both upfront investment and ongoing treatment expenses. Wegovy starter pens begin at £79.99 for the 0.25mg dose, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to the maintenance dose of £209.99 (2.4mg). Our Intro Duo bundle combining 0.25mg and 0.5mg pens costs £169.99, providing your first eight weeks of treatment. New customers can apply code FIRST40 at checkout, whilst returning customers use DOSE25 for continued savings.
For those considering whether Wegovy has fewer side effects than Mounjaro, our bundle options provide treatment stability and convenience. The Intro Trio (0.25mg, 0.5mg, and 1mg) costs £299.99, covering your first 12 weeks of dose escalation. Our Ultimate Stability Trio provides three months of maintenance 2.4mg pens for £649.99. Both medications require ongoing treatment for sustained weight management, as clinical studies show patients typically regain approximately two-thirds of lost weight within one year of stopping treatment. EverydayMeds offers both Wegovy and Mounjaro options, allowing your prescriber to recommend the most suitable choice based on your individual side effect tolerance and treatment goals.
Clinical Evidence: Wegovy and Mounjaro Side Effect Profiles
When examining whether Wegovy has less side effects than Mounjaro through clinical evidence, the STEP trials for Wegovy (Wilding et al., NEJM, 2021) demonstrated that the most common adverse events were gastrointestinal, affecting approximately 74% of patients. These included nausea (44%), diarrhoea (30%), vomiting (25%), and constipation (24%), with most events being mild to moderate in severity. The majority of gastrointestinal side effects occurred during dose escalation phases and typically decreased over time as patients adapted to treatment.
Mounjaro's SURMOUNT trials showed similar gastrointestinal patterns, though the dual receptor mechanism may influence the specific side effect experience. Both treatments demonstrated that serious adverse events were relatively rare, occurring in fewer than 7% of patients across trials. The question of does Wegovy have less side effects than Mounjaro cannot be definitively answered through cross-trial comparisons due to different study designs, patient populations, and endpoints, making individual clinical assessment essential for treatment selection.
Understanding How Wegovy Works for Weight Management
Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone produced in your intestines when you eat. This medication works by binding to GLP-1 receptors in your brain's appetite control centres, specifically the hypothalamus, helping to reduce food cravings and promote feelings of fullness after smaller meals. The mechanism also slows gastric emptying, meaning food remains in your stomach longer, contributing to prolonged satiety. When considering does Wegovy have less side effects than Mounjaro, this single-pathway approach may suit individuals who prefer a more targeted mechanism. Additionally, Wegovy may help reduce the reward response to high-calorie foods, supporting long-term dietary changes alongside the prescribed reduced-calorie diet and increased physical activity. The once-weekly FlexTouch pen injection provides consistent medication levels, supporting steady appetite regulation throughout your treatment journey.
Your Wegovy Treatment Journey: Assessment to Delivery
Beginning your weight management journey whilst considering does Wegovy have less side effects than Mounjaro starts with EverydayMeds' comprehensive 3-minute online clinical assessment. This evaluation covers your medical history, current medications, weight management goals, and any previous experiences with GLP-1 treatments to help determine suitability. Our qualified prescribers review your assessment within 3 working days (or 24 hours with express service), ensuring thorough evaluation of your individual risk factors and treatment preferences. Once approved, your Wegovy prescription is dispensed from our GPhC-registered pharmacy (#9012878) with full cold-chain integrity maintained throughout the process. Next-day delivery ensures your medication arrives in temperature-controlled packaging, ready for refrigerated storage between 2-8°C until first use.
Wegovy Storage Advantages and Practical Considerations
One practical advantage when evaluating does Wegovy have less side effects than Mounjaro relates to storage convenience and travel flexibility. Wegovy pens can remain at room temperature (below 30°C) for up to 6 weeks once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. This extended stability makes Wegovy particularly suitable for frequent travellers or those with inconsistent refrigeration access. The FlexTouch pen design provides clear dose viewing and simple injection technique, whilst the dose escalation schedule (0.25mg to 2.4mg over 16 weeks) allows gradual adaptation to treatment effects. Each pen contains four doses for weekly injections, and the medication should be stored in the original carton to protect from light. Proper injection site rotation between your thigh, upper arm, or abdomen helps minimise local reactions and maintains treatment effectiveness throughout your weight management journey.
Personalised Side Effect Assessment: Beyond General Comparisons
The question does Wegovy have less side effects than Mounjaro requires individualised consideration beyond population averages from clinical trials. Your personal medical history, including any digestive conditions, previous medication sensitivities, and concurrent health treatments, significantly influences how you might respond to either medication. Some patients experience fewer gastrointestinal effects with Wegovy's single GLP-1 pathway, whilst others may tolerate Mounjaro's dual mechanism better due to different dosing schedules and receptor activation patterns.
EverydayMeds' prescriber assessment process specifically evaluates your risk factors for common side effects, considering factors like gastroparesis history, gallbladder conditions, and family history of medullary thyroid carcinoma. This personalised approach helps determine whether Wegovy has less side effects than Mounjaro for your specific health profile. Our clinical team provides ongoing support throughout treatment, allowing dose adjustments or treatment switches if side effects become problematic, ensuring your weight management journey remains safe and effective.
Start Your Prescription Weight Loss Journey Today
Whether Wegovy has less side effects than Mounjaro for your individual situation can only be determined through proper clinical assessment and, potentially, supervised trial periods. EverydayMeds provides both treatment options with comprehensive prescriber guidance, starting from £79.99 with new customer code FIRST40 applied at checkout. Our GPhC-registered pharmacy (#9012878) ensures you receive genuine, MHRA-licensed medications with full clinical oversight throughout your treatment. Both Wegovy and Mounjaro are available from EverydayMeds, and your prescriber can help determine which treatment aligns best with your health profile and side effect tolerance. Visit our Wegovy collection to begin your clinical assessment and take the first step towards effective, medically supervised weight management. Your journey towards sustainable weight loss starts with the right treatment choice, proper medical guidance, and ongoing clinical support.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
